FDA NDC Directory · JSON-LD · Markdown

OGIVRI

NDC 67457-991 · HUMAN PRESCRIPTION DRUG · INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION

Generic nametrastuzumab
Labeler / ManufacturerMylan Institutional LLC
Marketing categoryBiologic License Application · App BLA761074
Dosage form / routeINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION · INTRAVENOUS
Active ingredientsTRASTUZUMAB (150 mg/7.4mL)
Marketing started20191129
Marketing ended20270228
Package count1

External sources

Source: openFDA. Public-domain (CC0).